Interferon-Alpha and its Effects on the Cytokine Cascade: A Pro- and Anti-Inflammatory Cytokine

References

• Isaacs A., Lindemann J. Virus interference. I. The interferon. Proc. R. Acad. Britain 1957; 147: 258–267
   PubMed Web of Science ®Google Scholar
• Finter N. B., Chapman S., Dowd P., et al. The use of interferon-α in virus infections. Drugs 1991; 42: 749–761
   PubMed Web of Science ®Google Scholar
• Talpaz M., Kantarjian H., Kurzrock R., Trujillo J. M., Guttermann J. U. Interferon-alpha produces sustained cytogenetic responses in chronic myelogeneic leukemia. Ann. Intern. Med. 1991; 114: 532–538
   PubMed Web of Science ®Google Scholar
• Di Bisceglie A. M., Martin P., Kassianides C., et al. Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N. Engl. J. Med. 1989; 321: 1506–1511
   PubMed Web of Science ®Google Scholar
• Mitsuyasu R. T. Use of recombinant interferons and hematopoietic growth factors in patients infected with human immunodeficiency virus. Rev. Infect. Dis. 1991; 13: 979–991
   PubMedGoogle Scholar
• Volz M. A., Kirkpatrick C. H. Interferons 1992. How much of the promise has been realized?. Drugs 1992; 43: 285–294
   PubMed Web of Science ®Google Scholar
• Borden E. C. Interferons-expanding therapeutic roles. N. Engl. J. Med. 1992; 326: 1491–1493
   PubMed Web of Science ®Google Scholar
• Guttermann J. U. Cytokine therapeutics: Lessons from interferon α. Proc. Natl. Acad. Sci. 1995; 91: 1198–1205
   Web of Science ®Google Scholar
• Sacchi S., Kantarjian H., O'Brien S., Cohen P. R., Pirce S., Talpaz M. Immune-mediated and unsusual complications during interferon alfa therapy in chronic myelogenous leukemia. J. Clin. Oncol. 1995; 13: 2401–2407
   PubMed Web of Science ®Google Scholar
• Kiely P. D., Bruckner F. E. Acute arthritis following in-terferon-alpha therapy. Br. J. Rheumatol. 1994; 33: 502–503
   PubMedGoogle Scholar
• Sugano S., Yanagimoto M., Suzuki T., et al. Retinal complications with elevated circulating plasma C5a associated with in-terferon-alpha therapy for chronic active hepatitis C. Am. J. Gastroenterol. 1994; 89: 2054–2056
   PubMed Web of Science ®Google Scholar
• Sotomatsu M., Shimoda M., Ogawa C., Morikawa A. Acute pancreatitis associated with interferon-alpha therapy for chronic myelogenous leukemia. Am. J. Hematol. 1995; 48: 211–212
   PubMed Web of Science ®Google Scholar
• Durand J. M., Retornaz F., Cretel E., Kaplanski G., Souberand J. Cresentic glomerulonephritis during treatment with interferon-alpha 2b. Am. J. Hematol. 1995; 48: 140–141
   PubMed Web of Science ®Google Scholar
• Stewart T. A., Hultgren B., Huang X., et al. Induction of type I diabetes by interferon-alpha in transgenic mice. Science 1993; 260: 1942–1946
   PubMed Web of Science ®Google Scholar
• Hladik F., Tratkiewicz J., Tilg H., et al. Biologic activity of low dosage IL-2 treatment in vivo. J. Immunol. 1994; 153: 1449–1454
   PubMed Web of Science ®Google Scholar
• Aulitzky W. G., Gastl G., Aulitzky W. E., et al. Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-γ. J. Clin. Oncol. 1989; 7: 1875–1882
   PubMed Web of Science ®Google Scholar
• Brinkmann V., Geiger T., Alkan S., Heusser C. H. Interferon a increases the frequency of interferon γ-producing human CD4+ T cells. J. Exp. Med. 1993; 178: 1655–1663
   PubMed Web of Science ®Google Scholar
• Dinarello C. A. The interleukin-1 family: 10 years of discovery. FASEB J. 1994; 8: 1314–1325
   PubMed Web of Science ®Google Scholar
• Carter D. B., Deibel M. R. J., Dunn C. J., et al. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature 1990; 344: 633–638
   PubMed Web of Science ®Google Scholar
• Eisenberg S., Brewer M. T., Verderber E., Heimdal P., Brandhuber B. J., Thompson R. C. IL-1 receptor antagonist is a member of the IL-1 gene family. Proc. Natl. Acad. Sci. 1991; 88: 5232–5236
   PubMed Web of Science ®Google Scholar
• Schindler R., Ghezzi P., Dinarello C. A. IL-1 induces IL-1. IV. IFNγ suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. J. Immunol. 1990; 144: 2216–2222
   PubMed Web of Science ®Google Scholar
• Tilg H., Mier J. W., Vogel W., et al. Induction of circulating IL-1 receptor antagonist by IFN treatment. J. Immunol. 1993; 150: 4687–4692
   PubMed Web of Science ®Google Scholar
• Huang Y., Blatt L. M., Tylor M. W. Type I interferon as an antiinflammatory agent: Inhibition of lipopolysaccharide-induced interleukin-1β and induction of interleukin-1 receptor antagonist. J. Interferon Cytokine Res. 1995; 15: 317–321
   PubMed Web of Science ®Google Scholar
• Aulitzky W. E., Peschel C., Despres D., et al. Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia. Ann. Hematol. 1993; 67: 205–211
   PubMed Web of Science ®Google Scholar
• Oliviera I. C., Scuavolino P. J., Lee T. H., Vilcek J. Downregulation of interleukin-8 gene expression in human fibroblasts: Unique mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci. 1992; 89: 9043–9048
   Google Scholar
• Aman M. J., Rudolf G., Goldschmitt G., et al. Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells. Blood 1993; 82: 2371–2382
   PubMed Web of Science ®Google Scholar
• Beutler B., Cerami A. The biology of cachectin/TNF— A primary mediator of the host response. Ann. Rev. Immunol. 1989; 7: 625–638
   PubMed Web of Science ®Google Scholar
• Olsson I., Gatanaga T., Gullberg U., Lantz M., Granger G. A. Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy. Eur. Cytokine Netw. 1993; 4: 169–178
   PubMed Web of Science ®Google Scholar
• Abu-Khabar K. S., Armstrong J. A., Ho M. Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cells. J. Leukoc. Biol. 1992; 52: 165–172
   PubMed Web of Science ®Google Scholar
• Romquin N., Billard C. Autocrine loop of tumor necrosis factor induced by interferon-alpha in tumor cells from hairy cell leukemia. Leukemia 1995; 9: 87–94
   PubMed Web of Science ®Google Scholar
• Garcia-Monzon C., Garcia-Buey L., Garcia-Sanchez A., Pajares J. M., Moreno-Otero R. Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa 2-b. Gastroenterology 1993; 105: 462–470
   PubMed Web of Science ®Google Scholar
• Tzung S. P., Mahl T. C., Lance P., Andersen V., Cohen S. A. Interferon-alpha prevents endotoxin-induced mortality in mice. Eur. J. Immunol. 1993; 22: 3097–3104
   Web of Science ®Google Scholar
• Tilg H., Vogel W., Dinarello C. A. Interferon-α induces circulating tumor necrosis factor receptor p55 in humans. Blood 1995; 85: 433–435
   PubMed Web of Science ®Google Scholar
• Aggarwal B. B., Pandita R. Both type I and type II interferons down-regulate human tumor necrosis factor receptors in human hepatocellular carcinoma cell line Hep G2. Role of protein kinase C. FEBS—Lett. 1994; 337: 99–102
   PubMed Web of Science ®Google Scholar
• Moore K. V., O'Garra A., De Waal Malefyt R., Vieira P., Mosmann T. R. Interleukin-10. Ann. Rev. Immunol. 1993; 11: 165–179
   PubMed Web of Science ®Google Scholar
• Arnason B. G. W. Neurology 1993; 43: 641–643
   PubMed Web of Science ®Google Scholar
• Huber C., Batchelor R., Fuchs D., et al. Immune response associated production of neopterin: release from macrophages primarily under control of interferon gamma. J. Exp. Med. 1984; 160: 310–315
   PubMed Web of Science ®Google Scholar
• Gisslinger H., Svoboda T., Clodi M., et al. Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 1993; 57: 489–495
   PubMed Web of Science ®Google Scholar
• KÜHn R., LÖHler J., Rennick D., Rajewsky K., MÜLler W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75: 263–274
   PubMed Web of Science ®Google Scholar
• Cohen R. D., Hanauer S. B. Immunomodulatory agents and other medical therapies in inflammatory bowel diseases. Curr. Op. Gastroenterol. 1995; 11: 321–330
   Web of Science ®Google Scholar
• Gasche C., Reinisch W., Wirth H. P., et al. Treatment of chronic active Crohn's disease with interferon alpha. Gastroenterology 1994; 106: A685
   Web of Science ®Google Scholar
• Ensoli B., Nakamura S., Salahuddin Z., et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989; 243: 223–226
   PubMed Web of Science ®Google Scholar
• MÜLler C., Bergmann K. F., Gerin J. L., Korba B. E. Production of hepatitis B virus by stably transfected monocytic cell line: a model for extrahepatic hepatitis B virus replication. J. Infect. Dis. 1992; 165: 929–935
   PubMed Web of Science ®Google Scholar
• Granowitz E. V., Saget B. M., Wang M. Z., Dinarello C. A., Skolnik P. R. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: Blockade by interleukin-1 receptor antagonist and tumor necrosis factor binding protein type 1. Molecular Medicine 1995; 1: 667–677
   PubMed Web of Science ®Google Scholar
• Poli G., Kinter A. L., Fauci A. S. Interleukin-1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl Acad. Sci. 1994; 91: 108–112
   PubMed Web of Science ®Google Scholar
• Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 1990; 59: 783–836
   PubMed Web of Science ®Google Scholar
• Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993; 81: 2844–2853
   PubMed Web of Science ®Google Scholar
• Mochizuki D. Y., Eisenman J. F., Conlon P. J., Larsen A. D., Tushinski R. J. Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc. Natl. Acad. Sci. USA 1987; 84: 5267–5272
   PubMed Web of Science ®Google Scholar
• Yang Y.-C., Tsai S., Wong G. G., Clark S. C. Interleukin-1 regulation of hematopoietic growth factor production by human stromal fibroblasts. J. Cell Physiol 1988; 134: 292–299
   PubMed Web of Science ®Google Scholar
• Fibbe W. E., Gosenlink H. M., Van Eeden G., Van Damme J., Biliau A., Voogt P. J., Willemze R., Falkenburg J. H. F. Proliferation of myeloid progenitorcells in human long-term bone marrow cultures is stimulated by interleukin-1 beta. Blood 1988; 72: 1242–1250
   PubMed Web of Science ®Google Scholar
• Van Damme J., Opdenakker G., Simpson R. J., Rubira M. R., Cayphas S., Vink A., Biliau A., Van Snick J. Identification of the human 26 kD protein, interferon b2 (IFN-b2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J. Exp. Med. 1987; 165: 914–922
   PubMed Web of Science ®Google Scholar
• Elias J. A., Zheng T., Whiting N. L., Trow T. K., Merrill W. W., Zitnik R., Ray P., Alderman E. M. IL-1 and transforming growth factor-beta regulation of fibroblast-derived IL-11. J. Immunol. 1994; 152: 2421–2429
   PubMed Web of Science ®Google Scholar
• Yang L., Yang Y. C. Regulation of interleukin (IL)-11 gene expression in IL-1 induced primate bone marrow stromal cells. J. Biol. Chem. 1994; 269: 32732–32739
   PubMed Web of Science ®Google Scholar
• Aye M. T., Hashemi S., Leclair B., Zeibdawi A., Trudel E., Halpenny M., Fuller V., Cheng G. Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow cells (CFU-RF). Exp. Hematol. 1992; 20: 523–527
   PubMed Web of Science ®Google Scholar
• Koenig A., Yakisan E., Reuter M., Huang M., Sykora K. W., Corbacioglu S., Welte K. Differential regulation of stem cell factor mRNA expression in human endothelial cells by bacterial pathogens: an in vitro model of inflammation. Blood 1994; 83: 2836–2843
   PubMed Web of Science ®Google Scholar
• Kantarjian H. M., Deisseroth A., Kurzrock R., Estrov Z., Talpaz M. Chronic myelogenous leukemia: A concise update. Blood 1993; 82: 691–703
   PubMed Web of Science ®Google Scholar
• Aulitzky W. E., Peschel C., Schneller F., Huber C. Biotherapy of chronic myelogenous leukemia. Ann. Hematol. 1995; 70: 113–120
   PubMed Web of Science ®Google Scholar
• Silver R. T. A new treatment for polycythemia vera: Recombinant interferon alpha. Blood 1990; 76: 664–665
   PubMed Web of Science ®Google Scholar
• Giles F. J., Singer C. R., Gray A. G., Yong K. L., Brozovic M., Davies S. C., Grant I. R., Hoffbrand A. V., Machin S. J., Mehta A. B. Alpha-interferon therapy for essential thrombo-cythaemia. Lancet 1988; 2: 70–72
   PubMed Web of Science ®Google Scholar
• Vilcek J. In Peptide growth factors and their receptors II, M. B. Sporn, A. B. Roberts. Springer Verlag, New York, NY 1990; 3–42
   Google Scholar
• Broxmeyer H. E., Lu L., Platzer E., Feit C., Juliano L., Rubin B. Y. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-e) and granulocyte-macrophage (CFU-GM) progenitor cells. J. Immunol. 1983; 131: 1300–1305
   PubMed Web of Science ®Google Scholar
• Raefsky E. L., Platanias L. C., Zoumbos N. C., Young N. S. Studies of interferon as a regulator of hematopoietic cell proliferation. J. Immunol. 1985; 135: 2507–2512
   PubMed Web of Science ®Google Scholar
• Ganser A., Carlo-Stella C., Greher J., Volkers B., Hoelzer D. Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Blood 1987; 70: 1173–1179
   PubMed Web of Science ®Google Scholar
• Geissler D., Gastl G., Aulitzky W. E., Tilg H., Gaggl S., Konwalinka G., Huber C. Recombinant interferon alpha-2c in chronic myelogenous leukemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro. Leuk. Res. 1990; 14: 629–636
   PubMed Web of Science ®Google Scholar
• Dowding C., Guo A. P., Maisin D., Gordon M. Y., Goldman J. M. The effects of interferon-alpha on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M-BCR breakpoint. Brit. J. Haematol. 1991; 77: 165–171
   PubMed Web of Science ®Google Scholar
• Mazur E. M., Richtsmeier W. J., South K. Alpha-interferon: differential suppression of colony growth from human erythroid, myeloid, and megakaryocytic hemopoietic progenitor cells. J. Interferon Res. 1986; 6: 199–206
   PubMedGoogle Scholar
• Galvani D. W., Cawley J. C. Mechanism of action of alpha interferon in chronic granulocytic leukaemia: evidence for preferential inhibition of late progenitors. Brit. J. Haematol. 1989; 73: 475–479
   PubMed Web of Science ®Google Scholar
• DesprÉS D., Goldschmitt J., Aulitzky W. E., Huber C., Peschel C. Differential effect of type I interferons on hematopoietic progenitor cells: Failure of IFNs to inhibit immaturemyeloid progenitor cells from normal bone marrow and chronic myelogeneous leukemia. Exp. Hematol. 1995, (in press)
   PubMed Web of Science ®Google Scholar
• Aman M. J., Keller U., Derigs G., Mohamadzadeh M., Huber C., Peschel C. Regulation of cytokine expression by interferon alpha in human bone marrow stromal cells: Inhibition of hematopoietic growth factors and induction of IL-1 receptor antagonist. Blood 1994; 83: 4142–4150
   Google Scholar
• Du X. X., Doerschuk C. M., Orazi A., Williams D. A. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 1994; 83: 33–37
   PubMed Web of Science ®Google Scholar
• Aman M. J., Bug G., Huber C., Peschel C. Inhibition of interleukin-11 by interferon-alpha in human bone marrow stromal cells. Exp. Hematol. 1995, (in press)
   Web of Science ®Google Scholar
• Graham G. J., Wright E. G., Hewick R., Wolpe S. D., Wilkie N. M., Donaldson D., Lorimore S., Pragnell I. B. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 1990; 344: 442–444
   PubMed Web of Science ®Google Scholar
• Peschel C., Bug G., Aman M. J., Derigs G., Huber C. Tissue specific regulation of the expression of macrophage inflammatory protein 1a (MlP-1a). Exp. Hematol. 1995; 23: 93, (Abs)
   Google Scholar